Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Coronary Artery Disease

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00019501-200608000-00003PMID 16845248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pivotal role of plasminogen‐activator inhibitor 1 in vascular disease

  2005cited by this paper
• Genetic contributors toward increased risk for ischemic heart disease.

  2005cited by this paper
• Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

  2005cited by this paper
• Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

  2004cited by this paper
• Pathobiology of atherosclerosis: are there racial and ethnic differences?

  2004cited by this paper
• Factor V G1691A, Prothrombin G20210A, and Methylenetetrahydrofolate Reductase [MTHFR] C677T Gene Polymorphism in Angiographically Documented Coronary Artery Disease

  2004cited by this paper
• Genetic Basis of Atherosclerosis: Part II: Clinical Implications

  2004cited by this paper
• Nitric Oxide, Atherosclerosis and the Clinical Relevance of Endothelial Dysfunction

  2004cited by this paper
• Multilocus Analysis of Hypertension: A Hierarchical Approach

  2004cited by this paper
• Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions

  2003cited by this paper
• The association of homocysteine and coronary artery disease

  2003cited by this paper
• MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

  2002cited by this paper
• Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.

  2001cited by this paper
• Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction

  2001cited by this paper
• 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

  2000cited by this paper
• Combinations of variations in multiple genes are associated with hypertension.

  2000cited by this paper
• Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine β-synthase and 5,10-methylenetetrahydrofolate reductase

  2000cited by this paper
• Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.

  2000cited by this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism, Coronary Thrombosis, and Myocardial Infarction in Middle-aged Finnish Men who Died Suddenly

  2000cited by this paper
• Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity

  2000cited by this paper
• [Genetic polymorphisms of homocysteine metabolism related enzymes in patients with coronary heart disease].

  1999cited by this paper
• Model-Free Analysis and Permutation Tests for Allelic Associations

  1999cited by this paper
• Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease.

  1999cited by this paper
• High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

  1998cited by this paper
• PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.

  1998cited by this paper
• Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene.

  1997cited by this paper
• Genetic data analysis II

  1997cited by this paper
• A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene

  1996cited by this paper
• Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population.

  1996cited by this paper
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Molecular and statistical approaches to the detection and correction of errors in genotype databases.

  1993cited by this paper
• Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.

  1991cited by this paper

• Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots.

  2017cites this paper
• Endothelial Nitric Oxide Synthase (eNOS) 4b/a Gene Polymorphisms and Coronary Artery Disease: Evidence from a Meta-Analysis

  2014influential citation
• Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Coronary Artery Disease: An Updated Meta-Analysis and Systematic Review

  2014cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

  2014cites this paper
• Functionally stable plasminogen activator inhibitor-1 in a family with cardiovascular disease and vitiligo

  2014cites this paper
• Gene Polymorphism and Coronary Heart Disease

  2012cites this paper
• [Coronary artery disease from a perspective of genomic risk score, ethical approaches and suggestions].

  2012cites this paper
• Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy

  2011cites this paper
• Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease

  2011cites this paper
• Lack of Association between Glutathione S-Transferase-M1, -T1, and -P1 Polymorphisms and Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients

  2010cites this paper
• 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries

  2010cites this paper
• The Endothelial Nitric Oxide Synthase Gene Is Associated with Coronary Artery Disease: A Meta-Analysis

  2010cites this paper
• Association study between glutathione S‐transferase GST‐M1, GST‐T1, and GST‐P1 polymorphisms and tardive dyskinesia

  2009cites this paper
• Distribution of Endothelial Nitric Oxide Synthase Gene Polymorphisms in Turkish Population

  2009cites this paper
• A comparison of analytical methods for genetic association studies

  2008cites this paper